about
Unsung Hero Robert C. GalloImmature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation.Identification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan PatientsSystems Biology Approach for Cancer Vaccine Development and EvaluationSystems biology applied to vaccine and immunotherapy developmentPlant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches.Development of a stable insect cell line constitutively expressing rotavirus VP2.Functional characterization of biodegradable nanoparticles as antigen delivery system.High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation.Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculationComparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells.HIV p24 as scaffold for presenting conformational HIV Env antigens.Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders.Translating tumor antigens into cancer vaccinesKaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy.Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian exampleEffects of adjuvants on IgG subclasses elicited by virus-like particles.Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration.Molecular immune signatures of HIV-1 vaccines in human PBMCsHPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.Infectious Agents and Cancer reviewer acknowledgement 2015Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer.Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer.Molecular and phylogenetic analysis of HIV-1 variants circulating in ItalyCharacterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolateIdentification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.Virus-like particle vaccines and adjuvants: the HPV paradigm.
P50
Q22065525-0DC75980-6666-4B9C-8469-92BFCCFE1CA6Q25257050-BD0FDDD5-A9D1-4259-AE67-D78266065807Q26778220-6CD8E8E7-2A7E-4FCE-8559-B96D5FD3B53CQ26782580-8AA2CE0D-D540-4FD2-B8B2-F7936B4FE830Q26830374-8E348D0A-62CF-4D4C-A939-03EBDD69B586Q30392083-15B0AFF1-5EAD-4467-980D-60148FAD0EC6Q30425503-2C27E189-EB86-47DA-853F-AA2232A65F2BQ30667121-6060CC80-4B36-40FC-9D6F-60BD57E4D9EBQ31887679-48778D67-3C23-4674-9EF4-32DE43DB2144Q33326902-AC635BB5-FE32-432F-AC8F-91F0DBA989E6Q33706203-4FDCF3EA-1DB1-45BF-BD01-EA634C6D9EB2Q33788701-C737256D-7DFB-47FD-BA38-8754A25AD163Q33798276-AB4258AA-E59D-4C4D-AF76-09940C502746Q34239911-97CEB8C2-600C-4BD6-901F-47448FF0871AQ34291543-7F88AF32-7C47-4B8B-A854-08577AEF954FQ34389522-F0600D20-20DD-4921-9AEF-B5FA97B4D0A5Q34427560-CFF6CCFA-80EE-4949-AC97-C27423329659Q34484042-E89C3939-5401-462C-A288-81D8DE098498Q34653644-CA77B8C6-5D67-43B6-8010-F7E417F60C81Q35107234-3D8FAF1C-5AB4-426A-ADC6-91A14637BEB5Q35206102-5C08D5A7-A238-4487-84BC-2405A4E06D09Q35241908-44ABDDA0-B771-479F-9E37-F540FA0AC6E5Q35605295-AD979877-E3CB-4ED8-98A3-F3C72DE06837Q35843775-3C5D6A0D-6E58-4B60-9FE2-D3A895FF039DQ35848642-A3F2ED24-8A90-43F4-8C58-F440DD673ED4Q35962518-6F7F9177-6DDD-454F-8E84-895B79D36D25Q36017750-A1EF0ECC-851D-4B67-A6DA-F3B61444D4C2Q36162887-1824BA75-0D83-40AE-A670-7935DA62EF4CQ36480261-EEB893A4-B025-4514-AA3E-E700CC118D45Q36570470-75CF559A-D8E5-443D-BC00-C67934265F32Q36618666-A59DA108-AEF8-458C-ACE3-AE5E4D396B44Q36646159-941BAE16-0CFA-4494-B3BC-F2DDA6C030BBQ36890494-755665CE-8186-41EB-8387-47492E12F82CQ36981930-30BB91F2-8506-4122-A36A-C86E73A553B9Q37060319-ABDF3B83-4B5A-4E94-92C2-B1E927AF02AFQ37076019-47E54710-68E4-4FFE-A5FA-D3C4541BAEDBQ37295260-F2F977CF-941A-4BBE-A2CD-2CD85BBD337EQ37437190-0874857B-11FD-42BA-9E65-C1817B1C8107Q37594497-626FD636-2320-4A46-9100-235648664921Q37608311-1D30C0C9-1039-41DE-8936-9CCD62F525AE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Lina Tornesello
@ast
Maria Lina Tornesello
@en
Maria Lina Tornesello
@es
Maria Lina Tornesello
@nl
Maria Lina Tornesello
@sl
type
label
Maria Lina Tornesello
@ast
Maria Lina Tornesello
@en
Maria Lina Tornesello
@es
Maria Lina Tornesello
@nl
Maria Lina Tornesello
@sl
prefLabel
Maria Lina Tornesello
@ast
Maria Lina Tornesello
@en
Maria Lina Tornesello
@es
Maria Lina Tornesello
@nl
Maria Lina Tornesello
@sl
P1053
A-1564-2009
P106
P1153
6603331759
P21
P31
P3829
P3835
maria-lina-tornesello2
P496
0000-0002-3523-3264